Pharmacokinetic behavior of cyclophosphamide (Endoxan) in the human organism
Dold, U.W.; Gaertner, H.J.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 169-172
1972
ISSN/ISBN: 0070-4067 PMID: 4665637 Document Number: 44373
Document emailed within 1 workday
Related Documents
Singh, S. 1971: The teratogenicity of cyclophosphamide (endoxan-asta) in rats Indian Journal of Medical Research 59(7): 1128-1135Kumar, S.; Raghunath, P.N.; Joseph, C.D.; Vasudevan, D.M. 1985: Studies with MPG against the side effects of cyclophosphamide (Endoxan)--a preliminary study Indian Journal of Cancer 22(3): 228-232
Mietkiewski, K.; Karoń, H.; Warchol, J.B.; Król, C. 1973: Effect of cyclophosphamide (endoxan) on histochemical reactions in the liver. I. Histoenzymatic studies Patologia Polska 24(1): 145-155
Foerster, H.; Lierse, W. 1975: Vulnerability of early postnatal differention processes of the retina and the teratogenic effect of cyclophosphamide (Endoxan) Acta Anatomica 93(2): 161-170
Lauria, F.; Baccarani, M.; Fiacchini, M.; Frezza, R.; Gobbi, M.; Tura, S. 1978: 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas Cancer Treatment Reports 62(8): 1193-1197
Singh, S.; Tuli, S.M.; Gupta, P.K. 1971: Skeletal defects induced by cyclophosphamide (endoxan-asta) in chick embryos--preliminary report Acta Orthopaedica Scandinavica 42(3): 217-226
Beijnen, J.H.; van Gijn, R.; Challa, E.E.; Kaijser, G.P.; Underberg, W.J. 1992: Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(4): 111-116
Steudtner, G. 1973: Behavior of the organism in the premorbid state Das Deutsche Gesundheitswesen 28(8): 351-360
Schomerus, M.; Eichelbaum, M.; Stieren, B.; Spiegelhalter, B.; Dengler, H.J. 1976: Pharmacokinetic behavior of verapamil in man Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1697-1699
Vicuna, N.; Lalka, D.; Burrow, S.R.; McLean, A.J.; du Souich, P.; McNay, J.L. 1978: Dose-dependent pharmacokinetic behavior of lidocaine in the conscious dog Research Communications in Chemical Pathology and Pharmacology 22(3): 485-491
Lewandowicz, J. 1974: Zinc and its significance in the human organism Wiadomosci Lekarskie 27(16): 1489-1492
Tsiskarishvili, N.V.; Nadareishvili, L.N.; Tsiskarishvili, T.I. 2011: New possibilities for elimination of human papillomavirus from the organism Georgian Medical News 192: 34-38
Piruzian, L.A.; Protasova, O.V.; Maksimova, I.A.; Morukov, B.V.; Protasov, S.V.; Ushakov, I.B. 2012: Magnesium level in human organism during 105-day isolation Aviakosmicheskaia i Ekologicheskaia Meditsina 46(3): 28-31
Müller, P.; Dammann, H.G.; Langer, M.; Leucht, U.; Simon, B. 1989: Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs Zeitschrift für Gastroenterologie 27(2): 83-86
Boguszewska, A.; Pasternak, K. 2004: Mercury-influence on biochemical processes of the human organism Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 59(2): 524-527
Kovalenko, V.P.; Pastukhov, V.V. 1983: Effects of intermittent exposure to low temperatures on the human organism Voenno-Meditsinskii Zhurnal 1: 49-51
Kosmider, S.; Misiewicz, A. 1976: Effects of sulfur and nitrogen oxides on the human organism Wiadomosci Lekarskie 29(16): 1429-1433
Rybka, J.; Novosad, P. 1984: Reaction of human organism to exercise. I. Theoretical part Acta Universitatis Carolinae. Medica 30(5-6): 251-295
Lehnert, G. 1973: Burdening of the human organism through toxic waste products Medizinische Monatsschrift 27(11): 484-486
Lüderitz, P. 1972: Demonstrable effects of carbon monoxide on the human organism Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 18(12): 898-903